Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bussink

Showing results (31-40 of 220) with videos related to

Pageof 22
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2022
Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer TreatmentSimone C Kleinendorst, Egbert Oosterwijk, Johan Bussink, et al.
Cellular Immunology|February 16, 2021
Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironmentVera M Kho, Vera E Mekers, Paul N Span, et al.
Oncology Research|May 4, 2019
Changes in DNA Damage Repair Gene Expression and Cell Cycle Gene Expression Do Not Explain Radioresistance in Tamoxifen-Resistant Breast CancerAnnemarie E M Post, Johan Bussink, Fred C G J Sweep, et al.
Cancers|April 3, 2021
Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell LinesEva-Leonne Göttgens, Marleen Ansems, William P J Leenders, et al.
Acta Oncologica (Stockholm, Sweden)|August 7, 2015
Epidermal growth factor receptor imaging in human head and neck cancer xenograftsLaura K van Dijk, Otto C Boerman, Johannes H A M Kaanders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2012
Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacyTineke W H Meijer, Johannes H A M Kaanders, Paul N Span, et al.
Seminars in Cancer Biology|June 1, 2014
Therapeutic targeting of autophagy in cancer. Part I: molecular pathways controlling autophagyAnika Nagelkerke, Fred C G J Sweep, Anneke Geurts-Moespot, et al.
Seminars in Cancer Biology|June 17, 2014
Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagyAnika Nagelkerke, Johan Bussink, Anneke Geurts-Moespot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2007
Concurrent celecoxib versus placebo in patients with stage II-III non-small cell lung cancer: a randomised phase II trialDirk De Ruysscher, Johan Bussink, Patrick Rodrigus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkageMorten Busk, Michael R Horsman, Steen Jakobsen, et al.
Pageof 22

Showing results (31-40 of 220) with videos related to

Sort By:
Pageof 22
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2022
Combining Targeted Radionuclide Therapy and Immune Checkpoint Inhibition for Cancer TreatmentSimone C Kleinendorst, Egbert Oosterwijk, Johan Bussink, et al.
Cellular Immunology|February 16, 2021
Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironmentVera M Kho, Vera E Mekers, Paul N Span, et al.
Oncology Research|May 4, 2019
Changes in DNA Damage Repair Gene Expression and Cell Cycle Gene Expression Do Not Explain Radioresistance in Tamoxifen-Resistant Breast CancerAnnemarie E M Post, Johan Bussink, Fred C G J Sweep, et al.
Cancers|April 3, 2021
Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell LinesEva-Leonne Göttgens, Marleen Ansems, William P J Leenders, et al.
Acta Oncologica (Stockholm, Sweden)|August 7, 2015
Epidermal growth factor receptor imaging in human head and neck cancer xenograftsLaura K van Dijk, Otto C Boerman, Johannes H A M Kaanders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2012
Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacyTineke W H Meijer, Johannes H A M Kaanders, Paul N Span, et al.
Seminars in Cancer Biology|June 1, 2014
Therapeutic targeting of autophagy in cancer. Part I: molecular pathways controlling autophagyAnika Nagelkerke, Fred C G J Sweep, Anneke Geurts-Moespot, et al.
Seminars in Cancer Biology|June 17, 2014
Therapeutic targeting of autophagy in cancer. Part II: pharmacological modulation of treatment-induced autophagyAnika Nagelkerke, Johan Bussink, Anneke Geurts-Moespot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2007
Concurrent celecoxib versus placebo in patients with stage II-III non-small cell lung cancer: a randomised phase II trialDirk De Ruysscher, Johan Bussink, Patrick Rodrigus, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 7, 2008
Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkageMorten Busk, Michael R Horsman, Steen Jakobsen, et al.
Pageof 22